You are here

CymaBay Therapeutics to Report Fourth Quarter and Fiscal 2018 Financial Results on Thursday, February 28

NEWARK, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that it will host a conference call and live audio webcast on Thursday, February 28, 2019 at 4:30 p.m. Eastern Time to discuss financial results for the fourth quarter and fiscal year ended December 31, 2018 and to provide a business update.
Thursday, February 21, 2019 - 08:00